Related Articles
Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway